您的位置: 首页 > 农业专利 > 详情页

HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR
专利权人:
Bayer Pharma Aktiengesellschaft
发明人:
HÄRTER, Michael,KOSEMUND, Dirk,DELBECK, Martina,KALTHOF, Bernd,WASNAIRE, Pierre,SÜSSMEIER, Frank,LUSTIG, Klemens
申请号:
SG11201707577V
公开号:
SG11201707577VA
申请日:
2016.03.21
申请国别(地区):
SG
年份:
2017
代理人:
摘要:
The present application relates to novel thieno[2,3-d]pyrimidine-2,4-dione (“thienouracil”) derivatives bearing a particular type of (azaheterocyclyl)methyl substituent, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of pulmonary and cardiovascular disorders and of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充